Event Recaps

Read for a recap of trends in PEGS 2026. The event brought together industry leaders from the pharmaceutical and biotech sectors to discuss protein and antibody engineering, drug development, immunotherapy, radiotherapy, and AI/ ML-driven biologics research.

The 2026 ChAbS Annual Conference, “10 Years Together: Forging the Future of Antibody Therapeutics,” was held on May 9-10, 2026, in Cambridge, MA.

​Biointron’s 2026 Lunch & Learn was held at CIC Cambridge, MA on May 8, 2026. The session featured two guest speakers: Shashi Jatiani, PhD, Director of Strategic Partnerships at SeromYx Systems, and Lee Andrews, Associate Director of Bioanalytical Development at Visterra.

BIO Korea 2026 was held on Aprill 28-30, 2026, bringing together academic scholars and experts in the biopharma and healthcare industry to share the latest technology trends and engage in discussion.

Read on for key trends talked about during the conference: Antibody Therapeutics Xchange - Boston 2026, held on April 28.

The BioPlus Global Forum 2026, held alongside AACR, highlighted emerging antibody targets, next-generation modalities, and shifting global development dynamics, with a strong focus on GI oncology, early-stage innovation, and the growing influence of China in clinical strategy.

Read a recap of the AACR Annual Meeting 2026, held in San Diego, CA, from April 17–22, 2026, bringing together global leaders in cancer research, drug development, and translational medicine. AACR showcased advances in tumor biology, immunotherapy, precision medicine, and emerging therapeutic modalities, with a strong focus on translating mechanistic insights into next-generation cancer therapies.

IMMUNOLOGY2026 was held in Boston, MA, from April 15-19, 2026. The meeting highlighted a broad spectrum of scientific progress, from fundamental insights into immune cell biology to translational innovations shaping vaccines, antibody therapeutics, and immune-mediated disease treatment, under the central theme of translating discovery into clinical impact.

Read on for the key trends of the NextGen Biomed 2026 conference held in London from March 24-25, featuring discussions across the entire value chain, from antibody engineering advancements to sustainable practices in TIDES chemistry!

BIO Asia 2024 in Taiwan featured breakthroughs in biotech and antibodies. Biointron shares key takeaways that define trends in global biologics and innovation.

Our 2023 year‑end networking and game night gathered scientists, partners, and friends to share results, swap ideas, and celebrate antibody discovery that will fuel the next year.

Meet Biointron at Tsinghua and Peking University—discover graduate roles in antibody research, biotech operations, and fast‑track CRO programs that turn ideas into therapies.